期刊文献+

miR-590-5p介导lncRNA SNHG1信号影响卵巢癌细胞增殖的实验研究 被引量:3

miR-590-5p mediates lncRNA SNHG1 signal to affect ovarian cancer cell proliferation
下载PDF
导出
摘要 目的:探讨miR-590-5p在卵巢癌组织中的表达情况以及其对卵巢癌细胞增殖的影响及作用机制。方法:Real-time PCR和双荧光素酶实验确定miR-590-5p与lncRNA SNHG1之间的调控作用。Real-time PCR检测卵巢癌、癌旁组织以及卵巢癌细胞中miR-590-5p的表达。分别采用NC mimic或者miR-590-5p mimic转染两株卵巢癌细胞,CCK-8检测各组细胞的增殖情况。此外,Real-time PCR检测两株细胞中SOX2、RECK和YAP1的表达。结果:Real-time PCR结果显示下调SNHG1后miR-590-5p的表达显著升高。双荧光素酶结果显示转染miR-590-5p mimic和野生型SNHG1片段的细胞中荧光素酶的活性显著降低。此外,Real-time PCR结果显示miR-590-5p在卵巢癌组织中的表达水平显著低于癌旁组织。CaOV3、OV-90细胞中miR-590-5p的表达水平明显低于其他卵巢癌细胞。转染miR-590-5p mimic显著上调了CaOV3、OV-90细胞中miR-590-5p的表达并且抑制了这两株细胞的增殖,同时抑制了两株细胞中SOX2、RECK和YAP1的表达。结论:miR-590-5p的低表达与卵巢癌的进展密切相关,miR-590-5p能够介导SNHG1信号并且通过对其下游靶基因的调控抑制卵巢癌细胞的增殖。 Objective:To investigate the expression of miR-590-5p in ovarian cancer tissue and its effect on ovarian cancer cell proliferation and its mechanism.Methods:Real-time PCR and double luciferase experiments confirmed the regulatory effect between miR-590-5p and lncRNA SNHG1.Real-time PCR was used to detect the expression of miR-590-5p in ovarian cancer tissues,adjacent tissues and ovarian cancer cells.NC mimic or miR-590-5p mimic were used to transfect two ovarian cancer cells respectively,and CCK-8 was used to detect the proliferation of each group of cells.In addition,Real-time PCR detected the expression of SOX2,RECK and YAP1 in the two cell lines.Results:Real-time PCR showed that miR-590-5p expression was significantly increased after SNHG1 was downregulated.Dual-luciferase results showed that luciferase activity in cells transfected with miR-590-5p mimic and wild-type SNHG1 fragments was significantly reduced.In addition,the Real-time PCR results showed that the expression level of miR-590-5p in CaOV3 and OV-90 cells was significantly lower than that in other ovarian cancer cells.Transfection of miR-590-5p mimic significantly increased the expression of miR-590-5p in CaOV3 and OV-90 cells and significantly inhibited the proliferation of the two cells,while inhibiting the expression of SOX2,RECK and YAP1 in two cells.Conclusion:The low expression of miR-590-5p is closely related to the progression of ovarian cancer.miR-590-5p can mediate SNHG1 signal and inhibit the proliferation of ovarian cancer cells by regulating its downstream target genes.
作者 宋洋 任芳 Song Yang;Ren Fang(Shengjing Hospital Affiliated to China Medical University,Liaoning Shenyang 110000,China)
出处 《现代肿瘤医学》 CAS 2020年第14期2365-2369,共5页 Journal of Modern Oncology
基金 国家自然科学基金青年科学基金项目(编号:81501235)。
关键词 miR-590-5p lncRNA SNHG1 卵巢癌 增殖 miR-590-5p lncRNA SNHG1 ovarian cancer proliferation
  • 相关文献

参考文献15

二级参考文献69

  • 1Roel NUSSE.Wnt signaling in disease and in development[J].Cell Research,2005,15(1):28-32. 被引量:85
  • 2刘巍峰,于珊珊,陈冠军,李越中.DNA损伤检验点与损伤修复及基因组稳定性(英文)[J].Acta Genetica Sinica,2006,33(5):381-390. 被引量:5
  • 3Siegel R ,Naishadham D, Jemal A. Cancer statistics ,2012 [ J ]. CA Cancer J Clin,2012,62( 1 ) :10 -29.
  • 4Hennessy BT,Coleman RL,Markman M. Ovarian cancer[ J]. Lan- cet,2009,374 (9698) : 1371 - 1382.
  • 5Vergote I, Trop CG, Amant F, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIc or IV ovarian cancer [ J ]. N Engl J Med,2010,363 (10) :943 -953.
  • 6King MC, Marks JH, Mandell JB. Group TNYBCS, for the New York Breast Cancer Study Group. Breast.and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 [ J]. Science, 2003,302:643 - 646.
  • 7Panici PB, Maggioni A, Hacker N, et al. Systematic aortic and pel- vic lymphadenectomy versus resection of bulky nodes only in opti- mally debulked advanced ovarian cancer:a randomized clinical trial [J]. J Natl Cancer Inst,2005,97:560 -566.
  • 8Aletti GD, Gostout BS, Pedratz KC, et al. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon [ J]. Gynecol Ouco1,2006 ,100 :33 - 34.
  • 9du Bois A,Reuss A,Pujade - Lauraine E,et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 muhicenter trials: by the Arbeitsgemeinschaft Gynaekolo- gische Onkologie Studiengruppe Ovarialkarzinom (AGO -OVAR) and the Groupe d "Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire ( GINECO ) [ J ]. Cancer, 2009,115 : 1234 - 1244.
  • 10Trimbos JB, Parmar M, Vergote I, et al. International Collaborative Ovarian Neoplasml, and the European Organisation for Research and Treatment of Cancer Collaborators - Adjuvant Chemotherapy un Ovarian Neoplasm. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant Chemotherapy In Ovarian Neoplasm trial:two parallel randomized phase III trials of adjuvant chemotherapy in pa- tients with early -stage ovarian carcinoma[ J]. J Natl Cancer Inst,2003,95:105 - 111.

共引文献172

同被引文献22

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部